Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| K01AT009894 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Center for Complementary and Integrative Health (NCCIH) | NIH |
Not provided
Not provided
Not provided
Not provided
Parkinson's Disease (PD) is defined by characteristic motor symptoms including slow movements, small movements, difficulty with movement initiation and disruptions in timing. Besides gross motor symptoms, fine motor impairments in PD cause difficulties with everyday tasks such as writing, self-care, and fine object manipulation. These activity limitations can lead to disability, social isolation, and a reduced quality of life. In a series of breakthrough studies Michael Thaut and colleagues developed Neurologic Music Therapy (NMT) and found it can address many gross motor impairments and improve gait and balance. Other music therapies such as Music-supported Therapy (MST) have proven motor benefits in stroke patients through movement exercises with musical instruments. However, the pathological basal ganglia (BG) in PD brains leads to a reduced supply of those internally generated movements. In contrast, externally cued movements (eg. via a beat or a rhythm) during NMT sessions are instantaneously entrained to the period of a rhythmic stimulus possibly without involvement of the BG. The underlying idea is that rhythm is the essential component relating music specifically to motor behavior. The mechanism of action is called "rhythmic entrainment" where one system's motion or signal frequency entrains the frequency of another system. The effect of NMT on fine motor function has not been investigated yet. Music activities are important in the lives of many older adults. Notably, the use of music has been associated with increased well-being for older adults, as it fosters social connection and mood regulation. Furthermore, many musical activities have limited physical demands, making them attainable for individuals who are living with mobility impairments or other physical restrictions. Based on the literature and the investigators preliminary studies, the investigators propose to test the efficacy of Neurologic Music Therapy in comparison to Music Supported Therapy and Occupational Therapy (OT) as standard of care on adults in the Parkinson's spectrum. The investigators have defined a working plan using different musical instruments and growing tempo to specifically improve fine motor movements.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Neurologic Music Therapy (NMT) | Experimental | Neurologic Music Therapy is a 5-week intervention using different musical instruments and auditory cues to specifically improve fine motor movements. |
|
| Occupational Therapy (OT) | Active Comparator | Standard of care occupational therapy uses traditional motor training. |
|
| Waitlist Control | No Intervention | Participants assigned to the waitlist-control condition will not immediately receive services. The no-treatment duration for these participants is yoked to the amount of time their respective NMT- and OT-condition participants receive services (5 weeks). After the wait period, these participants will then be randomized to receive either NMT, MST or OT sessions. | |
| Music Supported Therapy (MST) | Active Comparator | Music Supported Therapy uses musical instruments to train fine motor movements. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Neurologic Music Therapy | Other | Neurologic Music Therapy uses rhythms to change brain activity and function. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Clinical Outcome: Motor 1 (change in the Grooved Pegboard Test) | First motor outcome will be a change in the Grooved Pegboard Test. | Baseline and 5 weeks |
| Quality of Life (QOL) Outcome: QOL 1 (change in the 39-Item Parkinson's Disease) | First QOL outcome will be a change in the 39-Item Parkinson's Disease Questionnaire. | Baseline and 5 weeks |
| Mechanistic Outcome: Neurophysiology 1 (change in motor beta and gamma power using Magnetoencephalography) | Our first mechanistic outcome will be a change in cortical motor beta and gamma power using Magnetoencephalography. | Baseline and 5 weeks |
| Mechanistic Outcome: Neurophysiology 2 (change in auditory-motor functional connectivity using Magnetoencephalography) | Our second neurophysiology outcome will be a change in auditory-motor functional connectivity using Magnetoencephalography | Baseline and 5 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Clinical Outcome: Motor 2 (change in the Unified Parkinson Disease Rating Scale Part III) | Secondary motor outcome will be a change in the Unified Parkinson Disease Rating Scale Part III. | Baseline and 5 weeks |
| Clinical Outcome: Motor 3 (change in the Finger-Thumb opposition from the Neurological Evaluation Scale) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Lucas Lattanzio, BA | Contact | 303.724.2205 | Lucas.Lattanzio@CUAnschutz.edu | |
| Isabelle Buard, PhD | Contact | 303.724.5973 | Isabelle.Buard@CUAnschutz.edu |
| Name | Affiliation | Role |
|---|---|---|
| Isabelle Buard, PhD | University of Colorado, Denver | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Colorado Denver | Recruiting | Aurora | Colorado | 80045 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 34454592 | Derived | Buard I, Lattanzio L, Stewart R, Thompson S, Sjoberg K, Hookstadt K, Morrow M, Holden SK, Sillau S, Thaut M, Kluger B. Randomized controlled trial of neurologic music therapy in Parkinson's disease: research rehabilitation protocols for mechanistic and clinical investigations. Trials. 2021 Aug 28;22(1):577. doi: 10.1186/s13063-021-05560-7. |
Not provided
Not provided
De-identified data will be made available to the scientific community upon request.
Data sharing will include motor tests, questionnaires and MEG raw data.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010300 | Parkinson Disease |
| ID | Term |
|---|---|
| D020734 | Parkinsonian Disorders |
| D001480 | Basal Ganglia Diseases |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D009788 | Occupational Therapy |
| ID | Term |
|---|---|
| D012046 | Rehabilitation |
| D000359 | Aftercare |
| D003266 | Continuity of Patient Care |
| D005791 | Patient Care |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Occupational Therapy | Other | Occupational Therapy uses traditional motor training. |
|
| Music Supported Therapy | Other | Music Supported Therapy uses musical instruments to train fine motor movements. |
|
Secondary motor outcome will be a change in the Finger-Thumb opposition from the Neurological Evaluation Scale. |
| Baseline and 5 weeks |
| Quality of Life (QOL) Outcome: QOL 2 (change in the Clinical Global Impression - Improvement Scale) | Second QOL outcomes will be a change in the Clinical Global Impression - Improvement Scale . | Baseline and 5 weeks |
| Quality of Life (QOL) Outcome: QOL 3 (change in the Hospital Anxiety and Depression Scale) | Second QOL outcomes will be a change in the Hospital Anxiety and Depression Scale. | Baseline and 5 weeks |
| D009422 | Nervous System Diseases |
| D009069 | Movement Disorders |
| D000080874 | Synucleinopathies |
| D019636 | Neurodegenerative Diseases |
| D013812 |
| Therapeutics |